Chain length specificity for activation of cPLA2α by C1P: use of the dodecane delivery system to determine lipid-specific effects

Dayanjan S. Wijesinghe, Preeti Subramanian, Nadia F. Lamour, Luciana B. Gentile, María H. Granado, Alicja Bielawska, Zdzisław M. Szulc, Antonio Gómez‐Muñoz, Charles E. Chalfant

Journal of Lipid Research · 2008 · 54 citations · 24 references

DOIFull text

Open access

Concepts

Abstract

Previously, our laboratory demonstrated that ceramide-1-phosphate (C1P) specifically activated group IVA cytosolic phospholipase A2 (cPLA2α) in vitro. In this study, we investigated the chain length specificity of this interaction. C1P with an acyl-chain of ≥6 carbons efficiently activated cPLA2α in vitro, whereas C2-C1P, was unable to do so. Delivery of C1P to cells via the newly characterized ethanol/dodecane system demonstrated a lipid-specific activation of cPLA2α, AA release, and PGE2 synthesis (EC50 = 400 nM) when compared to structurally similar lipids. C1P delivered as vesicles in water also induced a lipid-specific increase in AA release. Mass spectrometric analysis demonstrated that C1P delivered via ethanol/dodecane induced a 3-fold increase in endogenous C1P with little metabolism to ceramide. C1P was also more efficiently delivered (>3-fold) to internal membranes by ethanol/dodecane as compared to vesiculated C1P. Using this now established delivery method for lipids, C2-C1P was shown to be ineffective in the induction of AA release as compared with C6-C1P, C16-C1P, and C18:1 C1P. Here, we demonstrate that C1P requires ≥6 carbon acyl-chain to activate cPLA2α. Thus, published reports on the biological activity of C2-C1P are not via eicosanoid synthesis. Furthermore, this study demonstrates that the alcohol/dodecane system can be used to efficiently deliver exogenous phospholipids to cells for the examination of specific biological effects.—Wijesinghe, D. S., P. Subramanian, N. F. Lamour, L. B. Gentile, M. H. Granado, A. Bielawska, Z. Szulc, A. Gomez-Munoz, and C. E. Chalfant. Chain length specificity for activation of cPLA2α by C1P: use of the dodecane delivery system to determine lipid-specific effects. Previously, our laboratory demonstrated that ceramide-1-phosphate (C1P) specifically activated group IVA cytosolic phospholipase A2 (cPLA2α) in vitro. In this study, we investigated the chain length specificity of this interaction. C1P with an acyl-chain of ≥6 carbons efficiently activated cPLA2α in vitro, whereas C2-C1P, was unable to do so. Delivery of C1P to cells via the newly characterized ethanol/dodecane system demonstrated a lipid-specific activation of cPLA2α, AA release, and PGE2 synthesis (EC50 = 400 nM) when compared to structurally similar lipids. C1P delivered as vesicles in water also induced a lipid-specific increase in AA release. Mass spectrometric analysis demonstrated that C1P delivered via ethanol/dodecane induced a 3-fold increase in endogenous C1P with little metabolism to ceramide. C1P was also more efficiently delivered (>3-fold) to internal membranes by ethanol/dodecane as compared to vesiculated C1P. Using this now established delivery method for lipids, C2-C1P was shown to be ineffective in the induction of AA release as compared with C6-C1P, C16-C1P, and C18:1 C1P. Here, we demonstrate that C1P requires ≥6 carbon acyl-chain to activate cPLA2α. Thus, published reports on the biological activity of C2-C1P are not via eicosanoid synthesis. Furthermore, this study demonstrates that the alcohol/dodecane system can be used to efficiently deliver exogenous phospholipids to cells for the examination of specific biological effects.—Wijesinghe, D. S., P. Subramanian, N. F. Lamour, L. B. Gentile, M. H. Granado, A. Bielawska, Z. Szulc, A. Gomez-Munoz, and C. E. Chalfant. Chain length specificity for activation of cPLA2α by C1P: use of the dodecane delivery system to determine lipid-specific effects. The first report of a biological effect for ceramide-1-phosphate (C1P) was by Gomez-Munoz et al. (1Gomez-Munoz A. Duffy P.A. Martin A. O'Brien L. Byun H.S. Bittman R. Brindley D.N. Short-chain ceramide-1-phosphates are novel stimulators of DNA synthesis and cell division: antagonism by cell-permeable ceramides.Mol. Pharmacol. 1995; 47: 833-839PubMed Google Scholar), which demonstrated that short chain (not naturally found in cells) C1P induced DNA synthesis in Rat-1 fibroblasts. Later, treatment of T17 fibroblasts with long chain, natural C1P was also demonstrated to induce a potent increase in DNA synthesis (2Gomez-Munoz A. Frago L.M. Alvarez L. Varela-Nieto I. Stimulation of DNA synthesis by natural ceramide 1-phosphate.Biochem. J. 1997; 325: 435-440Crossref PubMed Scopus (122) Google Scholar) and the levels of proliferating nuclear antigen. Following this line of research, a recent report demonstrated that C1P prevented programmed cell death in bone marrow-derived macrophages after withdrawal of macrophage colony-stimulating factor (3Gomez-Munoz A. Kong J.Y. Parhar K. Wang S.W. Gangoiti P. Gonzalez M. Eivemark S. Salh B. Duronio V. Steinbrecher U.P. Ceramide-1-phosphate promotes cell survival through activation of the phosphatidylinositol 3-kinase/protein kinase B pathway.FEBS Lett. 2005; 579: 3744-3750Crossref PubMed Scopus (132) Google Scholar). Treatment of these cells with C1P effectively blocked the activation of caspases and prevented DNA fragmentation upon serum removal. In the same study, it was demonstrated that C1P treatment inhibited ceramide generation from acid sphingomyelinase (A-SMase). Finally, A-SMase was shown to be a direct target of C1P inducing inhibition of this enzyme (4Gomez-Munoz A. Kong J.Y. Salh B. Steinbrecher U.P. Ceramide-1-phosphate blocks apoptosis through inhibition of acid sphingomyelinase in macrophages.J. Lipid Res. 2004; 45: 99-105Abstract Full Text Full Text PDF PubMed Scopus (181) Google Scholar). In the last few years, a number of reports have continued to demonstrate distinct biological mechanisms regulated by the sphingolipid, C1P, and the enzyme responsible for its synthesis, ceramide kinase (CERK). For example, Hinkovska-Galcheva et al. (5Hinkovska-Galcheva V.T. Boxer L.A. Mansfield P.J. Harsh D. Blackwood A. Shayman J.A. The formation of ceramide-1-phosphate during neutrophil phagocytosis and its role in liposome fusion.J. Biol. Chem. 1998; 273: 33203-33209Abstract Full Text Full Text PDF PubMed Scopus (116) Google Scholar) demonstrated that CERK was activated in the context of phagocytosis in neutrophils after challenging the cells with formyl peptide and antibody-coated erythrocytes (FMLP/EIgG). Thus, these data demonstrated that C1P may play a distinct role in membrane fusion, possibly explaining the early finding that high levels of C1P are found in synaptic vesicles (6Bajjalieh S.M. Martin T.F. Floor E. Synaptic vesicle ceramide kinase. A calcium-stimulated lipid kinase that co-purifies with brain synaptic vesicles.J. Biol. Chem. 1989; 264: 14354-14360Abstract Full Text PDF PubMed Google Scholar). Our laboratory has also demonstrated a biological function for C1P as a direct activator of cPLA2α through interaction with the C2/CaLB domain (7Pettus B.J. Bielawska A. Subramanian P. Wijesinghe D.S. Maceyka M. Leslie C.C. Evans J.H. Freiberg J. Roddy P. Hannun Y.A. et al.Ceramide 1-phosphate a direct activator of cytosolic phospholipase Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar). with the that the for cPLA2α activation in to and B.J. Bielawska A. S. Roddy P. Hannun Y.A. kinase and acid Biol. Chem. Full Text Full Text PDF Scopus Google Scholar), demonstrated that C1P was a in the eicosanoid A role for CERK and its C1P, in a of has also in et al. S. M. kinase a of in Biol. Chem. 2004; Full Text Full Text PDF Scopus Google Scholar) demonstrated that treatment of cells of CERK in these cells the induced by a of biological to C1P, it an effect for chain of C1P can be to biological In this chain of C1P have to biological effects. For example, short chain are for the of C1P as for delivery to target In this et al. S. P. B. S. K. 1-phosphate in for an effect by and 1-phosphate.Biochem. J. PubMed Scopus Google Scholar) and et al. K. R. M. 1-phosphate through by a kinase in J. 2004; PubMed Scopus Google Scholar) that C2-C1P induced an increase in the levels in cells and Using the same et al. C. P. L. A. F. apoptosis in ceramide kinase Res. PubMed Scopus Google Scholar) a apoptosis and C2-C1P formation upon treatment of CERK and long chain C1P have also demonstrated to DNA (1Gomez-Munoz A. Duffy P.A. Martin A. O'Brien L. Byun H.S. Bittman R. Brindley D.N. Short-chain ceramide-1-phosphates are novel stimulators of DNA synthesis and cell division: antagonism by cell-permeable ceramides.Mol. Pharmacol. 1995; 47: 833-839PubMed Google A. Frago L.M. Alvarez L. Varela-Nieto I. Stimulation of DNA synthesis by natural ceramide 1-phosphate.Biochem. J. 1997; 325: 435-440Crossref PubMed Scopus (122) Google Scholar). Our the and C18:1 C1P, the lipid a in the activation of cPLA2α and synthesis of (7Pettus B.J. Bielawska A. Subramanian P. Wijesinghe D.S. Maceyka M. Leslie C.C. Evans J.H. Freiberg J. Roddy P. Hannun Y.A. et al.Ceramide 1-phosphate a direct activator of cytosolic phospholipase Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google B.J. Bielawska A. S. Roddy P. Hannun Y.A. kinase and acid Biol. Chem. Full Text Full Text PDF Scopus Google Scholar). have in P. to J. PubMed Scopus Google by specific kinase PubMed Google Scholar), cell survival J. S. K. D. in and PubMed Scopus Google Scholar), apoptosis J. of cell and apoptosis by lipid PubMed Scopus Google Scholar), and cell J. of cell and apoptosis by lipid PubMed Scopus Google Scholar), the these for C1P can be to cPLA2α In a recent by et al. L. C. M. P. N. M. A. N. F. A. et of ceramide-1-phosphate on on dodecane in the Lipid Res. Full Text Full Text PDF PubMed Scopus Google Scholar) demonstrated that dodecane to deliver phospholipids induced eicosanoid synthesis and of cell in a on the of this method of lipid In this we the system chain of C1P to not chain activate cPLA2α in and in Thus, to C2-C1P are not via activation of cPLA2α. In we also demonstrate C1P biological that are and distinct from structurally similar lipid as as the delivery this study that the alcohol/dodecane delivery system can be to study lipid-specific and lipid are Furthermore, the study demonstrates that for C1P are not via activation of eicosanoid cells from was from and ceramide-1-phosphate for the treatment of from via of by of the of C1P was by the of C1P used in the treatment of and dodecane are from and acid from and and from cells in and with and macrophages in with and For the was to the of the by and macrophage cells in with of and and cells after in and in in a C1P was in to a The of C1P from this was was to the ceramide to the The was on a was and used and dodecane a of by and to C1P was in The was The was to the C1P that the was to can be was and for a by The was to the and was used to the The of C1P in delivery was by C1P was to the in and to cells a of was used to on cells by the delivery and ceramide in was as a the same as the cPLA2α activity was in a in a of and The also with of and of cPLA2α in a of the an of in and in was to the lipid to a The was on for The was by of the enzyme and was by the of of The of acid was the as and of a phospholipase A2 from the cell Biol. Chem. Full Text PDF PubMed Google Scholar). of the for and from cells with and in with for Following was to and AA by for number of cells by as (7Pettus B.J. Bielawska A. Subramanian P. Wijesinghe D.S. Maceyka M. Leslie C.C. Evans J.H. Freiberg J. Roddy P. Hannun Y.A. et al.Ceramide 1-phosphate a direct activator of cytosolic phospholipase Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar) and by of AA by In AA release of and cells and in a of was and cells The cells with with and in with after of the the was and for The in the was a of the was used in for analysis of that of the was in The with was of the was in in of and of PGE2 The of with of PGE2 and of PGE2 The was and for The was and of was to and was to in the with for Following the in was a was by the of the was to the cells and the was for The was a of nM) a cells in in and The cells with of the cells with C1P in with to the and on the with for in in and an a with a ceramide was to to C1P in the of as D.S. A. Subramanian P. Z. Bielawska A. specificity of ceramide Lipid Res. 2005; Full Text Full Text PDF PubMed Scopus Google M. S. S. A specific ceramide kinase to levels of PubMed Scopus Google Scholar) and as D.S. A. Subramanian P. Z. Bielawska A. specificity of ceramide Lipid Res. 2005; Full Text Full Text PDF PubMed Scopus Google M. S. S. A specific ceramide kinase to levels of PubMed Scopus Google Scholar). cells a of and the of the cells in and to serum and for by and C1P that the lipid was in as by in water for The lipid to the cells a of and for the of the the cells in to The membranes of the cells by The internal membranes from the membrane by for The a cells in for lipid in and The membranes of the cells by by by through a was by a of the by Maceyka et al. M. S. S. a kinase Lett. 2004; PubMed Scopus Google Scholar). The for to the membrane and The for to the membrane and The for to the membrane and the of was a cells and The cells with and with of C1P ceramide for in the cells and in as S. Wang E. and analysis of by 2005; PubMed Scopus Google Scholar). The cell and by of cells was for The as by et al. S. Wang E. and analysis of by 2005; PubMed Scopus Google Scholar) and a system to a as S. Wang E. and analysis of by 2005; PubMed Scopus Google Scholar). treatment by a when to from chain of to carbons are in cells with and the more are reports as to the of chain as short as carbons H. M. the of in to and by ceramide Chem. PubMed Scopus Google Scholar) and have C2-C1P as an exogenous (1Gomez-Munoz A. Duffy P.A. Martin A. O'Brien L. Byun H.S. Bittman R. Brindley D.N. Short-chain ceramide-1-phosphates are novel stimulators of DNA synthesis and cell division: antagonism by cell-permeable ceramides.Mol. Pharmacol. 1995; 47: 833-839PubMed Google K. R. M. 1-phosphate through by a kinase in J. 2004; PubMed Scopus Google S. P. B. S. K. 1-phosphate in for an effect by and J. PubMed Scopus Google Scholar). In this study, the of chain of C1P to activate cPLA2α was this we and C18:1 C1P and an established in for cPLA2α. chain of C1P C2-C1P activated cPLA2α C2-C1P induced an increase in cPLA2α activity similar to that of our reports of and Thus, C1P requires an chain length of carbons for activation of cPLA2α. The recent report by et al. L. C. M. P. N. M. A. N. F. A. et of ceramide-1-phosphate on on dodecane in the Lipid Res. Full Text Full Text PDF PubMed Scopus Google Scholar) and demonstrated that the biological on in PGE2 synthesis and cell not lipid specific high of used and the delivered In our laboratory demonstrated that a lipid-specific effect on the activation of cPLA2α, induction of AA release, and eicosanoid synthesis was for C1P when of used via the delivery system (7Pettus B.J. Bielawska A. Subramanian P. Wijesinghe D.S. Maceyka M. Leslie C.C. Evans J.H. Freiberg J. Roddy P. Hannun Y.A. et al.Ceramide 1-phosphate a direct activator of cytosolic phospholipase Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google B.J. Bielawska A. S. Roddy P. Hannun Y.A. kinase and acid Biol. Chem. Full Text Full Text PDF Scopus Google Scholar). Furthermore, a study with and P. Maceyka M. N. S. S. kinase and survival of Lett. PubMed Scopus Google Scholar) demonstrated of cell when of C1P was delivered to cells via we that the of used when delivered via was the for these and to this lipid delivery system to the chain length specificity of C1P activation of cPLA2α in we first the of delivered via on cPLA2α AA release, and eicosanoid synthesis. Treatment of cells with a naturally sphingolipid, induced an increase in AA release with increase in PGE2 synthesis effect was with an of 400 C1P with C1P inducing a increase in AA release and PGE2 synthesis. treatment of cells with C1P activation of a and a increase in AA release, which to eicosanoid by our C1P effect on cell B.J. Bielawska A. Subramanian P. Wijesinghe D.S. Maceyka M. Leslie C.C. Evans J.H. Freiberg J. Roddy P. Hannun Y.A. et al.Ceramide 1-phosphate a direct activator of cytosolic phospholipase Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google P. Maceyka M. N. S. S. kinase and survival of Lett. PubMed Scopus Google Scholar), data not demonstrate that the effect of C1P on AA and PGE2 release was cells also in the same with of the and a direct of C1P, and C18:1 ceramide ceramide and on AA release in the as compared with treatment of cells with the for the PGE2 synthesis a similar of induction of induce AA release as as C1P on AA in with the of et al. L. C. M. P. N. M. A. N. F. A. et of ceramide-1-phosphate on on dodecane in the Lipid Res. Full Text Full Text PDF PubMed Scopus Google Scholar) not Thus, C1P a potent and specific of AA and PGE2 release in cells when of in the lipid specificity of cPLA2α cPLA2α from the to with the and membranes in cells (7Pettus B.J. Bielawska A. Subramanian P. Wijesinghe D.S. Maceyka M. Leslie C.C. Evans J.H. Freiberg J. Roddy P. Hannun Y.A. et al.Ceramide 1-phosphate a direct activator of cytosolic phospholipase Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar). to determine the lipid specificity of cPLA2α in we C1P the of cPLA2α with membranes cPLA2α to Treatment of cells with C1P for induced a increase of cPLA2α in the and membranes The same of the delivery effect on the of cPLA2α determine the activation of cPLA2α by C1P was on delivery of C1P by naturally C1P was in water and delivered to A increase in AA release C1P was In the of AA release in the macrophages was specific for C1P as not and effect are C1P activation of the eicosanoid of delivery and in a lipid-specific The of C1P to a compared with delivery by to the of the delivery of C1P as et al. L. C. M. P. N. M. A. N. F. A. et of ceramide-1-phosphate on on dodecane in the Lipid Res. Full Text Full Text PDF PubMed Scopus Google Scholar) that C1P delivered by was and its was not by this delivery that this on and metabolism may be to the induced by C1P delivered with the use of the determine the of C1P metabolism and cells with natural ceramide and C1P and the levels of these by C1P delivered by demonstrated a increase in the chain length group of endogenous C1P in cells The data also demonstrate that C1P was to ceramide in cells with a increase in C18:1 ceramide upon of C1P to a increase in ceramide in with the recent with et al. P. Maceyka M. N. S. S. kinase and survival of Lett. PubMed Scopus Google Scholar). Thus, natural C1P delivered in to cells not to ceramide the delivery of C1P as vesicles to the of this method for C1P to internal membranes when compared with the system not the of C1P, we used C1P to the of C1P delivered via delivery Following treatment C1P for the of C1P in the internal membranes was found to increase when delivered via vesicles Thus, C1P delivered via the method more in C1P to internal In to the membranes for lipid delivery by C1P was delivered and vesicles by as by our The delivery system was more C1P to internal the the and the when compared with the delivery system C1P was delivered by to the of cPLA2α compared with analysis the of in as Wijesinghe D.S. Maceyka M. Wang E. kinase ceramide by ceramide to of eicosanoid Lipid Res. Full Text Full Text PDF PubMed Scopus Google Scholar). and used to and membrane are specific for the and are not on these are used to the of the delivery system was established to deliver C1P to the and a lipid specific activation of cPLA2α, we investigated the of and C18:1 C1P treatment on the of C2-C1P in internal membranes to the same as the when delivered by the delivery system induction of AA release was not Thus, activation of a by C1P also chain length C2-C1P activate cPLA2α in we delivered short chain and long chain C1P to cells the The levels of membrane and cytosolic cPLA2α C1P treatment was analysis a increase of cPLA2α in the membrane of the C18:1 increase in cPLA2α in the membrane was in C2-C1P cells demonstrate that activation of cPLA2α to naturally C1P, we compared the of of C1P, C1P, and the naturally C1P to activate cPLA2α in and in with the natural C1P was not to activate cPLA2α in and was a of AA release from cells C1P, activated cPLA2α to the same as the naturally C1P. that the of C1P not for interaction with cPLA2α not our laboratory has the C1P on cPLA2α, which to a cPLA2α that to C1P has on the Subramanian P. M. Ceramide-1-phosphate group IVA cytosolic phospholipase via a novel in the Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). Using and cPLA2α, we investigated in to delivered by in analysis of the cPLA2α compared with the in to of the cPLA2α are the same as the we that activation of cPLA2α by C1P via a direct interaction and not through an effect of with the Our laboratory in that C1P delivered in cPLA2α in cells in a lipid-specific (7Pettus B.J. Bielawska A. Subramanian P. Wijesinghe D.S. Maceyka M. Leslie C.C. Evans J.H. Freiberg J. Roddy P. Hannun Y.A. et al.Ceramide 1-phosphate a direct activator of cytosolic phospholipase Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar). the chain length specificity of C1P for this interaction was not In in and C2-C1P was not to increase AA release this study demonstrates that an chain length of more carbons was for activation of cPLA2α. Furthermore, data from in which C1P was delivered in that the naturally are the potent of cPLA2α, with and C18:1 C1P a increase in AA release The that the of C1P was unable to activate cPLA2α the that activation of the enzyme in the of naturally of C1P. have to the biological mechanisms to exogenous C1P For example, C1P have shown in S. P. B. S. K. 1-phosphate in for an effect by and 1-phosphate.Biochem. J. PubMed Scopus Google K. R. M. 1-phosphate through by a kinase in J. 2004; PubMed Scopus Google Scholar). cPLA2α a calcium-stimulated it may be that the activation of cPLA2α by C1P to an increase in The data demonstrate that C1P not activation of cPLA2α in release AA through the activation of cPLA2α when delivered to Thus, the activation of cPLA2α by C1P not via an increase in the our that ceramide kinase for activation of cPLA2α by Furthermore, induction of release in to C2-C1P not via the of activation of cPLA2α and generation of a of release. Thus, the study also the of C2-C1P in the biological of C1P that are of the activation of cPLA2α. For example, the of DNA synthesis and cell by exogenous treatment with C1P (1Gomez-Munoz A. Duffy P.A. Martin A. O'Brien L. Byun H.S. Bittman R. Brindley D.N. Short-chain ceramide-1-phosphates are novel stimulators of DNA synthesis and cell division: antagonism by cell-permeable ceramides.Mol. Pharmacol. 1995; 47: 833-839PubMed Google Scholar) not to of the activation of cPLA2α and in C2-C1P now a to regulated by C1P. Furthermore, C2-C1P may also be used to direct of cPLA2α and study also that of cPLA2α to membranes in to C1P via a direct as C1P can now be used as a to C1P of cPLA2α. the mechanisms and the generation of C1P not this an to and via a direct increase in C1P. The that cPLA2α activated by long chain naturally C1P in with our D.S. A. Subramanian P. Z. Bielawska A. specificity of ceramide Lipid Res. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar) with to ceramide the enzyme to to C1P. of CERK for of carbons D.S. A. Subramanian P. Z. Bielawska A. specificity of ceramide Lipid Res. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar). demonstrate in CERK to the the of AA release by cPLA2α. Thus, it that ceramide by CERK C1P activation of cPLA2α. study also the recent by et al. L. C. M. P. N. M. A. N. F. A. et of ceramide-1-phosphate on on dodecane in the Lipid Res. Full Text Full Text PDF PubMed Scopus Google Scholar), which as to the lipid specificity of the activation of cPLA2α by C1P when delivered via the specifically that the of AA release in the macrophages and cells was specific for C1P as phospholipids as ceramide and to do so. The lipid-specific effect the use of of C1P as by our C1P demonstrated lipid specificity in the induction of AA release from In with the recent report by et al. L. C. M. P. N. M. A. N. F. A. et of ceramide-1-phosphate on on dodecane in the Lipid Res. Full Text Full Text PDF PubMed Scopus Google Scholar), lipid specificity was as of phospholipids The of lipid specificity with the of cell as by et al. P. Maceyka M. N. S. S. kinase and survival of Lett. PubMed Scopus Google Scholar) and et al. L. C. M. P. N. M. A. N. F. A. et of ceramide-1-phosphate on on dodecane in the Lipid Res. Full Text Full Text PDF PubMed Scopus Google Scholar). Thus, our study demonstrates that the the was the in of C1P C1P a specific activator of AA release and cPLA2α activation when are and of cell In with the lipid-specific effect of C1P on AA release, the data also that C1P in water with macrophages to induce AA release. was also found in cells with the use of the system not The that C1P can activate cPLA2α in the of also it interaction of the with the used for its delivery to cells in In this it be that the effect of C1P on of fibroblasts and the inhibition of apoptosis in bone marrow-derived macrophages C1P in water in the of (1Gomez-Munoz A. Duffy P.A. Martin A. O'Brien L. Byun H.S. Bittman R. Brindley D.N. Short-chain ceramide-1-phosphates are novel stimulators of DNA synthesis and cell division: antagonism by cell-permeable ceramides.Mol. Pharmacol. 1995; 47: 833-839PubMed Google A. Kong J.Y. Parhar K. Wang S.W. Gangoiti P. Gonzalez M. Eivemark S. Salh B. Duronio V. Steinbrecher U.P. Ceramide-1-phosphate promotes cell survival through activation of the phosphatidylinositol 3-kinase/protein kinase B pathway.FEBS Lett. 2005; 579: 3744-3750Crossref PubMed Scopus (132) Google A. Kong J.Y. Salh B. Steinbrecher U.P. Ceramide-1-phosphate blocks apoptosis through inhibition of acid sphingomyelinase in macrophages.J. Lipid Res. 2004; 45: 99-105Abstract Full Text Full Text PDF PubMed Scopus (181) Google Scholar). be delivered in as to that be when are to biological cells in high of the phospholipids are and in the of cell vesiculated phospholipids are not as efficiently to internal membranes In these the delivery system an for the of lipid In the study the from on the biological of delivered by study also demonstrates that the alcohol/dodecane delivery system can be used to biological by specific as long as are In to use of lipids, have on cell and which can of The metabolism of the lipid also of as as lipids, as as direct of similar be used as specificity of these to be established for specific cell as may be Furthermore, of of the lipid also be these this study demonstrates that the dodecane delivery system for can be used to study specific biological when to cell and Finally, this study also demonstrates that the interaction structurally specific with chain length an for activation of the Furthermore, from treatment of cells with C2-C1P be to cPLA2α activation and synthesis. with acid ceramide kinase ceramide-1-phosphate group IVA cytosolic phospholipase A2 acid sphingomyelinase

References

24